Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses

ABSTRACT We investigated how differences in age, sex, or vaccine type can affect humoral and cellular immune responses after vaccination with vector (ChAdOx1 nCoV-19), mix-and-match (first, ChAdOx1 nCoV-19, and second, BNT162b2), or mRNA (BNT162b2 or mRNA-1273) vaccines against severe acute respirat...

Full description

Bibliographic Details
Main Authors: Minjeong Nam, Seung Gyu Yun, Sang-wook Kim, Chris Gunwoo Kim, Jae Hyun Cha, Cheonghwa Lee, Seunghyuk Kang, Seul Gi Park, Sun Bean Kim, Ki-Byung Lee, You-Seung Chung, Myung-Hyun Nam, Chang Kyu Lee, Yunjung Cho
Format: Article
Language:English
Published: American Society for Microbiology 2022-08-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02495-21
_version_ 1811188258476916736
author Minjeong Nam
Seung Gyu Yun
Sang-wook Kim
Chris Gunwoo Kim
Jae Hyun Cha
Cheonghwa Lee
Seunghyuk Kang
Seul Gi Park
Sun Bean Kim
Ki-Byung Lee
You-Seung Chung
Myung-Hyun Nam
Chang Kyu Lee
Yunjung Cho
author_facet Minjeong Nam
Seung Gyu Yun
Sang-wook Kim
Chris Gunwoo Kim
Jae Hyun Cha
Cheonghwa Lee
Seunghyuk Kang
Seul Gi Park
Sun Bean Kim
Ki-Byung Lee
You-Seung Chung
Myung-Hyun Nam
Chang Kyu Lee
Yunjung Cho
author_sort Minjeong Nam
collection DOAJ
description ABSTRACT We investigated how differences in age, sex, or vaccine type can affect humoral and cellular immune responses after vaccination with vector (ChAdOx1 nCoV-19), mix-and-match (first, ChAdOx1 nCoV-19, and second, BNT162b2), or mRNA (BNT162b2 or mRNA-1273) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Venous blood was collected from 573 subjects (vector, 396; mix-and-match, 96; and mRNA, 81) before the first vaccination (T0), 7 to 8 weeks (vector) or 3 to 4 weeks (mRNA) after the first vaccination (T1), and 3 to 4 weeks after the second vaccination (T2). The humoral and cellular immune responses were evaluated using Elecsys anti-SARS-CoV-2 (Roche), Alinity SARS-CoV-2 IgG II Quant (Abbott), cPass SARS-CoV-2 neutralization antibody detection (GenScript), and QuantiFERON SARS-CoV-2 (Qiagen) kits. At T1, the levels of the receptor-binding domain antibodies (RBD Ab) and neutralizing antibodies (NAb) decreased with aging, but interferon gamma release (IGR) levels increased. The RBD Ab, NAb, and IGR levels were higher in females than in males at T1 and T2. The NAb levels were higher in the mix-and-match and mRNA vaccine groups than in the vector vaccine group at T2. The RBD Ab and IGR levels were higher in the mRNA vaccine group than in the vector or mix-and-match vaccine groups at T2. The optimal cutoffs for RBD Ab and NAb, which were used to determine the presence of T cell responses, were 5.7 binding antibody units per milliliter (BAU mL−1) and 12.0 IU mL−1, respectively. Age, sex, and vaccine type affected the humoral and cellular immune responses, and T cell responses could be estimated from RBD Ab and NAb levels. IMPORTANCE There have been few studies that comprehensively evaluated factors affecting immune responses and the correlation between humoral and cellular immune responses after vector, mix-and-match, and mRNA vaccines against SARS-CoV-2. Therefore, we analyzed the effects of age, sex, and the different vaccine regimens on the immune responses to vaccination against SARS-CoV-2. The correlation between humoral and cellular immune responses and the cutoffs were derived for RBD antibodies and neutralizing antibodies to predict the presence of the cellular immune responses. In this comprehensive study, we demonstrated that there were differences in the immune responses induced after vaccination depending on the age and sex of an individual. Among the three vaccine regimens, the mix-and-match and mRNA vaccines induced the most robust immune responses. Finally, the proposed optimal cutoffs for RBD and neutralizing antibodies may be useful for predicting cellular immune responses when assays for cellular immune responses are not available.
first_indexed 2024-04-11T14:17:06Z
format Article
id doaj.art-375101458c4e4f8e876df78c684e4a45
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-04-11T14:17:06Z
publishDate 2022-08-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-375101458c4e4f8e876df78c684e4a452022-12-22T04:19:14ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972022-08-0110410.1128/spectrum.02495-21Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune ResponsesMinjeong Nam0Seung Gyu Yun1Sang-wook Kim2Chris Gunwoo Kim3Jae Hyun Cha4Cheonghwa Lee5Seunghyuk Kang6Seul Gi Park7Sun Bean Kim8Ki-Byung Lee9You-Seung Chung10Myung-Hyun Nam11Chang Kyu Lee12Yunjung Cho13Department of Laboratory Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaGyeryong City Health, Gyeryong-si, Chungcheongnam-do, South KoreaDepartment of Laboratory Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University Anam Hospital, Seoul, South KoreaDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South KoreaABSTRACT We investigated how differences in age, sex, or vaccine type can affect humoral and cellular immune responses after vaccination with vector (ChAdOx1 nCoV-19), mix-and-match (first, ChAdOx1 nCoV-19, and second, BNT162b2), or mRNA (BNT162b2 or mRNA-1273) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Venous blood was collected from 573 subjects (vector, 396; mix-and-match, 96; and mRNA, 81) before the first vaccination (T0), 7 to 8 weeks (vector) or 3 to 4 weeks (mRNA) after the first vaccination (T1), and 3 to 4 weeks after the second vaccination (T2). The humoral and cellular immune responses were evaluated using Elecsys anti-SARS-CoV-2 (Roche), Alinity SARS-CoV-2 IgG II Quant (Abbott), cPass SARS-CoV-2 neutralization antibody detection (GenScript), and QuantiFERON SARS-CoV-2 (Qiagen) kits. At T1, the levels of the receptor-binding domain antibodies (RBD Ab) and neutralizing antibodies (NAb) decreased with aging, but interferon gamma release (IGR) levels increased. The RBD Ab, NAb, and IGR levels were higher in females than in males at T1 and T2. The NAb levels were higher in the mix-and-match and mRNA vaccine groups than in the vector vaccine group at T2. The RBD Ab and IGR levels were higher in the mRNA vaccine group than in the vector or mix-and-match vaccine groups at T2. The optimal cutoffs for RBD Ab and NAb, which were used to determine the presence of T cell responses, were 5.7 binding antibody units per milliliter (BAU mL−1) and 12.0 IU mL−1, respectively. Age, sex, and vaccine type affected the humoral and cellular immune responses, and T cell responses could be estimated from RBD Ab and NAb levels. IMPORTANCE There have been few studies that comprehensively evaluated factors affecting immune responses and the correlation between humoral and cellular immune responses after vector, mix-and-match, and mRNA vaccines against SARS-CoV-2. Therefore, we analyzed the effects of age, sex, and the different vaccine regimens on the immune responses to vaccination against SARS-CoV-2. The correlation between humoral and cellular immune responses and the cutoffs were derived for RBD antibodies and neutralizing antibodies to predict the presence of the cellular immune responses. In this comprehensive study, we demonstrated that there were differences in the immune responses induced after vaccination depending on the age and sex of an individual. Among the three vaccine regimens, the mix-and-match and mRNA vaccines induced the most robust immune responses. Finally, the proposed optimal cutoffs for RBD and neutralizing antibodies may be useful for predicting cellular immune responses when assays for cellular immune responses are not available.https://journals.asm.org/doi/10.1128/spectrum.02495-21cellular immune responseshumoral immune responsesvector vaccinemix-and-match vaccinemRNA vaccine
spellingShingle Minjeong Nam
Seung Gyu Yun
Sang-wook Kim
Chris Gunwoo Kim
Jae Hyun Cha
Cheonghwa Lee
Seunghyuk Kang
Seul Gi Park
Sun Bean Kim
Ki-Byung Lee
You-Seung Chung
Myung-Hyun Nam
Chang Kyu Lee
Yunjung Cho
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
Microbiology Spectrum
cellular immune responses
humoral immune responses
vector vaccine
mix-and-match vaccine
mRNA vaccine
title Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
title_full Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
title_fullStr Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
title_full_unstemmed Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
title_short Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
title_sort humoral and cellular immune responses to vector mix and match or mrna vaccines against sars cov 2 and the relationship between the two immune responses
topic cellular immune responses
humoral immune responses
vector vaccine
mix-and-match vaccine
mRNA vaccine
url https://journals.asm.org/doi/10.1128/spectrum.02495-21
work_keys_str_mv AT minjeongnam humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT seunggyuyun humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT sangwookkim humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT chrisgunwookim humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT jaehyuncha humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT cheonghwalee humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT seunghyukkang humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT seulgipark humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT sunbeankim humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT kibyunglee humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT youseungchung humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT myunghyunnam humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT changkyulee humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses
AT yunjungcho humoralandcellularimmuneresponsestovectormixandmatchormrnavaccinesagainstsarscov2andtherelationshipbetweenthetwoimmuneresponses